206650 — EuBiologics Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Market Cap
KR₩465bn
Enterprise Value
KR₩394bn
Revenue
KR₩96bn

Annual balance sheet for EuBiologics Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	53,088	31,545	11,044	9,897	22,854
Net Total Accounts Receivable
Net Total Receivables	6,383	3,917	5,547	12,099	12,076
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	71,407	53,720	41,139	41,764	83,143
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	68,538	70,046	72,815	70,096	76,100
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	155,955	150,438	162,066	151,806	202,085
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	35,197	17,282	24,624	25,699	43,044
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	59,079	30,439	37,556	40,433	70,052
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	96,877	119,999	124,510	111,373	132,033
Total Liabilities & Shareholders' Equity	155,955	150,438	162,066	151,806	202,085
Total Common Shares Outstanding